BOSTON, May 19, 2023 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data demonstrating the ...

Editas Medicine presents preclinical data on gene editing at ASGCT, aiming to develop candidates for hematopoietic and liver therapies by 2025. Quiver AI Summary.

"These exciting preclinical data underscore the enormous therapeutic potential of our gene editing systems to deliver a life-transforming therapy for patients suffering from Huntington’s disease ...

The right panel displays which data points will be shown in your view, and the order in which they’ll appear. You can drag and drop to arrange the columns according to your preferences.

Korro Bio recently began a Phase 1/2 test of KRRO-110, an RNA-editing therapy for AATD. Last summer, biotech startup AIRNA raised $60 million to advance to the clinic in 2025 with its experimental ...

Editing data and columns in Screener. Learn how to add, remove, and arrange data points. Share. Whether your screen is made up of your personal favorite data points or are imported from ...